Provided by Tiger Fintech (Singapore) Pte. Ltd.

MIRXES-B

42.260
+0.9002.18%
Volume:726.00K
Turnover:30.83M
Market Cap:11.66B
PE:-54.96
High:44.480
Open:41.300
Low:41.020
Close:41.360
52wk High:49.180
52wk Low:27.050
Shares:276.00M
HK Float Shares:276.00M
Volume Ratio:0.82
T/O Rate:0.26%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.769
ROE:--
ROA:-51.53%
PB:14.34
PE(LYR):-54.96
PS:70.69

Loading ...

Company Profile

Company Name:
MIRXES-B
Exchange:
SEHK
Establishment Date:
2014
Employees:
347
Office Location:
2 Tukang Innovation Grove,#09-02 JTC MedTech Hub,Singapore,Singapore
Zip Code:
618305
Fax:
- -
Introduction:
MiRXES Holding Company Limited is a micro ribonucleic acid (miRNA) technology company specializing in early cancer detection and precision medicine. It develops and commercializes accurate, non-invasive, and affordable blood-based miRNA test kit products for the early detection of cancer and other diseases. Its segments include Infectious diseases and Early detection and precision multi-omics. Its solutions include cancer screening; clinical sequencing; cancer treatment selection, and infectious diseases. Its core product (namely, GASTROClear), two other commercialized products (namely, LUNGClear and Fortitude), and six product candidates at pre-clinical stage. GASTROClear is a blood-based miRNA detection panel consisting of 12 miRNA biomarkers for gastric cancer screening. LUNGClear, its lung cancer screening product candidate, is a detection panel consisting of miRNA biomarkers discovered and verified in multi-center studies. It offers complete COVID-19 testing solutions.

Directors

Name
Position
ZHU Xing Fen
Chairman of the Board,Director,Audit Committee Member
ZHOU Li Han
Executive Director,Member of the Nomination Committee
ZOU Rui Yang
Executive Director
HE Hao Jie
Executive Director
LIN Qian Li
Independent Director,Member of the Remuneration and Assessment Committee,Audit Committee Chairman
FANG Xiao
Independent Director,Chairman of the Remuneration and Assessment Committee,Member of the Nomination Committee,Audit Committee Member
MA Lu Ling
Independent Director,Member of the Remuneration and Assessment Committee,Chairman of the Nomination Committee
LE Bei Lin
Director
LIU Da
Director

Shareholders

Name
Position
ZHOU Li Han
CEO
ZHU Ming Lu
CFO
ZOU Rui Yang
Deputy CEO,CTO
OU Yang Wei Zhi
Corporate Secretary
XIAO Yue Qiu
Corporate Secretary
HE Hao Jie
Chief Investment Officer
ZHU Xing Fen
Advisor